Cow's Milk Protein Allergy
11
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Hydrolysed Rice Formula Study
Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort Study
Dietary Restriction Efficiency Assessment in CMPA
Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy
Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of Elimination
Association of Renal-tubular Acidosis in Children With Cow Milk Protein Allergy
Tolerance and Growth Outcomes in Children Diagnosed With Cow's Milk Protein Allergy and Prescribed an Extensively Hydrolyzed Casein Formula (Damira 2000©) in Spain
The Journey of Children With Cow's Milk Protein Allergy in Mexico.
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula
Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides